Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study.
Chiricozzi A., Ferrucci S.M., Di Nardo L., Gori N., Balato A., Ortoncelli M., Maurelli M., Galluzzo M., Munera Campos M., Seremet T. et al., 2023. Expert opinion on biological therapy, 23 (12) pp. 1307-1315. Peer-reviewed.
ici le détail